Raphael Szalat

7PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Microelectromechanical systems (MEMS)HaematologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 29, 2026
Tailoring Therapy for Frail and Elderly Myeloma Patients.

|Oct 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

Mariateresa Fulciniti, Yao Yao, Tommaso Perini

|Sep 22, 2025
Bleeding Patterns and Clinical Outcomes in Patients With Systemic AL Amyloidosis-Related Acquired Factor X Deficiency.

Okan Cetin, Andrew Staron, Patric Teodorescu

|Jun 22, 2022
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study.

Joshua N Gustine, Andrew Staron, Raphael E Szalat

|Oct 08, 2020
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study.

Nathanael R Fillmore, Jennifer La, Raphael E Szalat

Pageof 2